Cardiology
News
DAPA-HF: Dapagliflozin benefits regardless of age, HF severity
PHILADELPHIA – The SGLT2 inhibitor had similar efficacy in the elderly, and across the spectrum of baseline symptom status.
News
Large population-based study underscores link between gout, CVD event risk
ATLANTA – The relationships between gout and fatal and nonfatal CVD events found in a large population-based health data linkage study in New...
News
Hyperkalemia-related treatment changes linked to death in acute HF
It’s not the potassium, but the subsequent dosage reduction, that may boost mortality after hospitalization for acute heart failure.
Video
DAPA-HF: Dapagliflozin’s HFrEF efficacy confirmed in nondiabetics
PHILADELPHIA –
Clinical
Risk stratification of syncope patients can help determine duration of telemetry monitoring
In ED patients with syncope, what is the optimal duration of telemetry monitoring to detect underlying arrhythmia?
Clinical
Better time data from in-hospital resuscitations
Acquiring accurate time-interval data is “the key to future high-quality research.”
Clinical
Aspirin for primary prevention reduces risk of CV events, increases bleeding
What is the association between aspirin for primary prevention and cardiovascular events and bleeding?
Clinical
Spanish risk score predicts 30-day mortality in acute HF in ED patients
Is the MEESSI-AHF score valid to use in EDs in Switzerland?
Clinical
Oral antibiotics as effective as IV for stable endocarditis patients
Can patients with left-sided endocarditis safely switch from intravenous to oral antibiotics?
All Content
New score predicts benefits of prolonged cardiac monitoring for TIA, stroke patients
How can we determine which patients would benefit from prolonged cardiac monitoring after a neurologic event?